Alnylam Pharmaceuticals, Inc. v. Dicerna Pharmaceuticals, Inc. (Lawyers Weekly No. 09-026-17)
Biotechnology company sued competitor for trade secret misappropriation; competitor's counterclaims for tortious interference and unfair competition survive anti-SLAPP motion when properly motivated by recovery for alleged wrongful conduct rather than intent to chill.